Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
Ibrutinib + Venetoclax in Untreated WM
ClinicalTrials.gov study NCT04273139. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03734016. IPD Sharing: YES. Countries: 15. Publications: 10.
Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT02077166. IPD Sharing: YES. Countries: 4. Publications: 2.
A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies
ClinicalTrials.gov study NCT03088878. IPD Sharing: NO. Countries: 1. Publications: 3.
Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT02332980. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
ClinicalTrials.gov study NCT01849263. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01886872. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT
ClinicalTrials.gov study NCT03689894. IPD Sharing: NO. Countries: 1. Publications: 26.
A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03323151. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve Chronic Lymphocytic Leukemia (CLL) or Small Lym
ClinicalTrials.gov study NCT02264574. IPD Sharing: YES. Countries: 16. Publications: 6.
Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02997761. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)
ClinicalTrials.gov study NCT02910583. IPD Sharing: YES. Countries: 6. Publications: 2.
Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL
ClinicalTrials.gov study NCT01722487. IPD Sharing: NO. Countries: 16. Publications: 9.
Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury
ClinicalTrials.gov study NCT04375397. IPD Sharing: YES. Countries: 1. Publications: 1.
Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT02562898. IPD Sharing: YES. Countries: 1. Publications: 1.
Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia
ClinicalTrials.gov study NCT02165397. IPD Sharing: YES. Countries: 9. Publications: 6.
Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers
ClinicalTrials.gov study NCT03332498. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT02048813. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03136497. IPD Sharing: NO. Countries: 1. Publications: 45.
A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy
ClinicalTrials.gov study NCT02717611. IPD Sharing: YES. Countries: 6. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.